Latest Recurrent Pregnancy Loss guidelines at ACOG
One of the highlights of attending the latest annual ACOG Clinical & Scientific meeting was joining a packed auditorium to hear Dr Ruth Lathi’s compelling lecture, “New Guidelines, New Hope for Recurrent Pregnancy Loss.” 📖 Dr. Lathi, the Director of the Multi-Specialty Recurrent Pregnancy Loss Program and Professor of Obstetrics and Gynecology at Stanford University …
WAM Forum Learnings
3 things I learned at the WAM Forum luncheon in Las Vegas! I was so delighted to be invited to attend the Women’s Alzheimer’s Movement forum networking breakfast and luncheon yesterday. Such an incredible group of people brought together to find collaboration and solutions for women’s health. Our bodies are pretty intertwined. Brain health is …
ACOG in Minneapolis
Spending time in Minneapolis for the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting was even better than I had hoped. Besides the constant engagement with passionate American OBGYNs (so many of which are excited to hear about our Callavid® drug delivery technology) – it was superb to connect with other …
HLTH Europe Startup Finalist
Delighted to be named a 2025 finalist in the HLTH Europe Startup Pitch, sponsored by Haleon! Honoured to share the stage with some of the most innovative healthtech startups in Europe. See you in Amsterdam. 🇳🇱
Naomi Aduroja joins as a Roivant Social Ventures Global Access Fellow
💥 A warm welcome to Naomi Aduroja who joins us as a Roivant Social Ventures Global Access Fellow this summer. Currently preparing for her third year in the prestigious PharmD program at UNC Eshelman School of Pharmacy – we’re delighted to have Naomi support various R&D projects leaning on her experience including from across pharmacy …
ACOG Clinical & Scientific Meeting in Minneapolis
We’re delighted to be in Minneapolis for the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting. From May 16th-18th, we’ll be ready to connect, collaborate, and showcase our Callavid® vaginal drug delivery innovation at the largest meeting of obstetricians and gynecologists in the US. This is an exciting opportunity to discuss …
Amy Coulson joins the Vaginal Microbiome team
We’re delighted to welcome Amy Coulson to CLCC in advance of starting her Ph.D. journey at Queen Mary University of London. Over the next 4 years she’ll be working with our team and QMUL’s Centre for Doctoral Training in Next Generation Organ on a Chip Technology (COaCT) to develop a vaginal organ-on-a-chip to grasp successful …
Discover CLCC’s B Corp Impact Report
We believe that true success in business must be measured not just by commercial milestones, but by the positive impact we create. To us, being a B Corp is more than a certification – it’s a daily commitment to balancing people, planet, profit, and purpose. B Lab’s rigorous standards provide a clear framework for accountability …
A RCT of progesterone luteal support for unexplained infertility
A promising new study published in the BJOG Journal (British Journal of Obstetrics and Gynaecology / Royal College of Obstetricians and Gynaecologists) explores the use of vaginal progesterone for couples facing unexplained infertility. 👀 Could this pave the way for broader use of vaginal progesterone prior to IVF —especially for those who can’t access IVF …
BBC Radio Spotlight: Professor Quenby on Transforming Miscarriage Treatment with Callavid®
🎧 We loved this recent BBC Radio interview with Professor Siobhan Quenby MBE, who is leading the clinical trial of our progesterone-loaded Callavid at University Hospitals Coventry and Warwickshire (UHCW) NHS Trust. 🔗 Listen to the clip: https://lnkd.in/e9GkFDaD Professor Quenby shares how our pioneering drug delivery technology could support women globally experiencing threatened miscarriage — …